Isoray Inc (ISR)
0.3674
+0.00 +1.24%
NYSE AM
Nov 27, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 9.749M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.05 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -3.343M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 52.27% |
| Profit Margin (Quarterly) | -29.91% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 32.05M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 2.562 |
| PE Ratio | -- |
| Price to Book Value | 6.290 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -0.451M |
| Return on Equity | Upgrade |
View All ISR News
News
-
WireHeadlineTime (ET)
-
Yahoo11/14 09:32
-
Yahoo11/10 18:05
-
SA Breaking News11/10 16:14
-
MT Newswires11/10 16:13
-
Yahoo11/10 14:30
-
Yahoo11/09 10:20
-
Yahoo11/03 12:30
-
SA Breaking News10/26 08:54
-
MT Newswires10/20 11:20
-
SA Breaking News10/20 09:25
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/11/2021 | Earnings | Isoray Inc Second Quarter Earnings for 2021 Release |
| 02/11/2021 16:30 EST | Misc | Isoray Inc Second Quarter Earnings Conference Call for 2021 |
| 11/10/2020 | Earnings | Isoray Inc First Quarter Earnings Result for 2021 |
| 11/10/2020 16:30 EST | Misc | Isoray Inc First Quarter Earnings Conference Call for 2021 |
| 09/25/2020 | Misc | Isoray Inc Annual Report for 2020 |
| 09/17/2020 | Earnings | Isoray Inc Fourth Quarter Earnings Result for 2020 |
| 09/17/2020 16:30 EDT | Misc | Isoray Inc Fourth Quarter Earnings Conference Call for 2020 |
| 05/12/2020 16:30 EDT | Misc | Isoray Inc Third Quarter Earnings Conference Call for 2020 |
| 05/12/2020 | Earnings | Isoray Inc Third Quarter Earnings Result for 2020 |
| 02/11/2020 16:30 EST | Misc | Isoray Inc Second Quarter Earnings Conference Call for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.isoray.com
- Investor Relations URL: https://isoray.com/about/investors/
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Equity Style: Small Cap/Blend
- Next Earnings Release: Feb. 11, 2021
- Last Earnings Release: Nov. 10, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products that provide more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to the cancerous tumor. It derives most of its revenue from the United States of America.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.3674 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ISR Tweets Stocktwits
Advertisement
